C18ORF8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.858400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.049370E-01
Normal-vs-Stage2
9.371800E-01
Normal-vs-Stage3
7.140400E-01
Normal-vs-Stage4
7.409400E-01
Stage1-vs-Stage2
2.141900E-03
Stage1-vs-Stage3
5.028200E-01
Stage1-vs-Stage4
3.635600E-02
Stage2-vs-Stage3
6.913800E-01
Stage2-vs-Stage4
6.368400E-01
Stage3-vs-Stage4
4.718000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.881800E-01
Normal-vs-AfricanAmerican
9.118800E-01
Normal-vs-Asian
8.502000E-01
Caucasian-vs-AfricanAmerican
9.381000E-01
Caucasian-vs-Asian
9.394800E-01
AfricanAmerican-vs-Asian
9.439200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.800200E-01
Normal-vs-Female
5.761400E-01
Male-vs-Female
1.052990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.978600E-01
Normal-vs-Age(41-60Yrs)
9.775200E-01
Normal-vs-Age(61-80Yrs)
8.642600E-01
Normal-vs-Age(81-100Yrs)
7.420600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.554640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.746600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.570000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.906000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.046600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.428400E-01
Normal-vs-Daily Drinker
9.114400E-01
Normal-vs-Weekly Drinker
9.539000E-01
Normal-vs-Occasional Drinker
7.272200E-01
Normal-vs-Social Drinker
8.602600E-01
Non Drinker-vs-Daily Drinker
7.939900E-02
Non Drinker-vs-Weekly Drinker
7.204000E-02
Non Drinker-vs-Occasional Drinker
1.542430E-01
Non Drinker-vs-Social Drinker
2.636000E-01
Daily Drinker-vs-Weekly Drinker
8.973000E-01
Daily Drinker-vs-Occasional Drinker
4.538800E-01
Daily Drinker-vs-Social Drinker
8.064000E-01
Weekly Drinker-vs-Occasional Drinker
5.138800E-01
Weekly Drinker-vs-Social Drinker
7.451800E-01
Occasional Drinker-vs-Social Drinker
5.312200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.865200E-01
Normal-vs-Grade 2
4.781600E-01
Normal-vs-Grade 3
5.932600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.941700E-02
Grade 1-vs-Grade 3
4.149600E-01
Grade 1-vs-Grade 4
8.865200E-01
Grade 2-vs-Grade 3
4.589600E-01
Grade 2-vs-Grade 4
4.781600E-01
Grade 3-vs-Grade 4
5.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.788200E-01
Normal-vs-NonDiabetic
8.642800E-01
Diabetic-vs-NonDiabetic
8.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.600600E-01
Normal-vs-NoPancreatitis
8.598200E-01
Pancreatitis-vs-NoPancreatitis
9.982200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.153800E-01
Normal-vs-N1
9.568200E-01
N0-vs-N1
3.521400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.230800E-01
Normal-vs-TP53-NonMutant
7.926000E-01
TP53-Mutant-vs-TP53-NonMutant
1.010420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
